Literature DB >> 3115649

A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus.

A el-Roeiy1, N Gleicher, D Isenberg, R C Kennedy, Y Shoenfeld.   

Abstract

Since the immune response in fetuses of mothers with systemic lupus erythematosus (SLE) is unknown, we investigated sera from six mothers and their paired offspring by enzyme-linked immunosorbent assay (ELISA) for the presence of a common anti-DNA idiotype (16/6 Id) and, as control, for the presence of an unrelated public idiotype of antibody to hepatitis B surface antigen (HBsAg). In addition, maternal as well as fetal sera were evaluated for the presence of antibodies to ssDNA, dsDNA, poly(I), poly (dT), RNA, cardiolipin, total histones and the presence of lupus anticoagulant. Clinically active SLE mothers showed in general increased IgG and, to a lesser extent, IgM autoantibody activity. Circulating lupus anticoagulant was detectable in clinically active mothers only. All offspring of clinically active SLE mothers showed increased IgG autoantibodies to a variety of antigens, while IgM antibodies were detected in only one fetus. In contrast, fetuses of clinically inactive mothers showed only minor IgG activity. Common anti-DNA-idiotype (16/6 Id) activity also correlated with disease activity in both maternal and fetal compartments. One clinically active mother was 16/6-negative; her offspring was, however, positive, indicating de novo production of the idiotype by the fetus. In contrast, a control anti-HBsAg idiotype was not detected in either maternal or fetal sera. It therefore appears that offspring of clinically active SLE mothers serologically reflect maternal disease activity. Furthermore, autoantibodies and common idiotype of autoantibodies can be found within the fetal compartment even in the absence of such antibodies in the maternal serum. Discrepancies between mothers and offspring in IgM-autoantibody levels and the presence of new idiotypes in fetuses are indicative of fetal de novo autoantibody production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115649      PMCID: PMC1542743     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Immunogenetics of the neonatal lupus syndrome.

Authors:  L A Lee; W B Bias; F C Arnett; J C Huff; D A Norris; C Harmon; T T Provost; W L Weston
Journal:  Ann Intern Med       Date:  1983-11       Impact factor: 25.391

2.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

3.  Pregnancy outcome in women with systemic lupus erythematosus.

Authors:  M L Gimovsky; M Montoro; R H Paul
Journal:  Obstet Gynecol       Date:  1984-05       Impact factor: 7.661

4.  Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas.

Authors:  Y Shoenfeld; J Rauch; H Massicotte; S K Datta; J André-Schwartz; B D Stollar; R S Schwartz
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

5.  Production of autoantibodies by human-human hybridomas.

Authors:  Y Shoenfeld; S C Hsu-Lin; J E Gabriels; L E Silberstein; B C Furie; B Furie; B D Stollar; R S Schwartz
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

6.  The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  W J Morrow; D J Williams; C Ferec; R Casburn-Budd; D A Isenberg; E Paice; M L Snaith; P Youinou; P Le Goff
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

7.  Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus.

Authors:  D A Isenberg; Y Shoenfeld; R S Schwartz
Journal:  Arthritis Rheum       Date:  1984-02

8.  Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block.

Authors:  J S Scott; P J Maddison; P V Taylor; E Esscher; O Scott; R P Skinner
Journal:  N Engl J Med       Date:  1983-07-28       Impact factor: 91.245

9.  Idiotypic cross-reactions of monoclonal human lupus autoantibodies.

Authors:  Y Shoenfeld; D A Isenberg; J Rauch; M P Madaio; B D Stollar; R S Schwartz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype.

Authors:  R C Kennedy; G R Dreesman
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

View more
  3 in total

1.  Long term prognosis of children born to lupus patients.

Authors:  A Murashima; T Fukazawa; M Hirashima; Y Takasaki; M Oonishi; S Niijima; Y Yamashiro; A Yamataka; T Miyano; H Hashimoto
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

Review 2.  The Significance of a Common Idiotype (1F7) on Antibodies against Human Immune Deficiency Virus Type 1 and Hepatitis C Virus.

Authors:  Sybille Muller; Matthew S Parsons; Heinz Kohler; Michael Grant
Journal:  Front Oncol       Date:  2016-02-05       Impact factor: 6.244

3.  Lack of autoantibody production associated with cytomegalovirus infection.

Authors:  Beth C Marshall; Richard A McPherson; Eric Greidinger; Robert Hoffman; Stuart P Adler
Journal:  Arthritis Res       Date:  2002-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.